Philip Clarke holds the Director of Centre for Health Policy at the Melbourne School of Population and Global Health, University of Melbourne. He has had previous appointments at Oxford University and the University of Sydney. He was involved in developing the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model; a computer simulation model for predicting outcomes for patients with Type 2 diabetes. He has expertise in economic evaluation alongside clinical trials, simulation modeling, measurement of health inequalities and international comparisons of drug prices. He has recently contributed to books on cost-effectiveness analysis and cost-benefit analysis published by Oxford University Press.
9:00 am - 5:00 pm
Evaluating Public Health Interventions using Economic and Epidemiologic MethodsTraining/Workshop
This new oneday short course run by Health Economics Unit providing an overview of how costeffectiveness analyses and costbenefit analysis can be used to evaluate public sector inventions, including screening and prevention programs, and ways to i...